Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
22
SRI International, an independent, nonprofit research and development organization, announced that it has been awarded a $1.55M U.S. Department of Defense/Prostate Cancer Research Program (DoD/PCRP) grant to support product- driven, preclinical studies of SRI's novel agents that have the potential to become prostate cancer drugs. The goal of the program is to discover treatments that can revolutionize the prevention, detection, or treatment of prostate cancer.
Clinical researchers at Princess Margaret Hospital (PMH) can now answer the question that baffles many clinicians - why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer?
The largest single-institution study of its kind has found few complications in prostate cancer patients treated with radiotherapy after surgery to remove the prostate. Men in this study received radiotherapy after a prostate-specific antigen (PSA) test following surgery indicated their cancer had recurred.
Cellular senescence is a persistently growth- arrested phenotype in normal and transformed cells induced by noncytotoxic stress. Cytostasis as a method of cancer treatment has recently generated significant interest, researchers in the United States report.
People who suffer from debilitating neuropathic pain may get more relief and sleep better by combining two commonly-prescribed drugs. A new, federally-funded study by Queen's University researchers has found that taking the drugs together is a more effective treatment than taking either of them individually.
20
Prostate cancer is the most commonly diagnosed and second leading cause of cancer deaths in men in the United States. If detected early, prostate cancer treatment is highly successful, but at present there are no known treatments for advanced metastatic disease.
19
Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that a research team at Northwestern University's International Institute for Nanotechnology found that an ultrasensitive nanoparticle-based assay, 300 times more sensitive than commercial immunoassays, is capable of detecting previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
15
A new study is raising some concerns about robotic prostate cancer surgery, a procedure widely used by local hospitals and promoted as having fewer complications than traditional prostate surgery.
Immune therapies have been explored as a way to treat cancer after it develops. But a new study from the University of Michigan Comprehensive Cancer Center suggests that genetic risk of prostate cancer can be reduced by rescuing critical immune system cells.
13
Over the last several years, unprecedented numbers of men have elected to undergo robotically assisted surgery for prostate cancer in the belief that the less invasive approach would give them a better chance of maintaining normal sexual function and avoiding incontinence.
We care about your feedback. Let us know how we can improve your CancerCompass experience.